,i  #aafth ,,congress  #b;d ,session    
,h4 ,r4 #hagg  ,,in ,,the ,,house ,,of  
,,representatives  ,september #d1 #bjbj 
,mr4 ,o',halleran 7for himself1 ,mr4    
,bucshon1 ,mr4 ,butterfield1 and ,mr4   
,mullin7 introduced the following bill2 
which was referred to the ,committee on 
,energy and ,commerce1 and in addition  
to the ,committee on ,ways and ,means1  
for a period to be subsequently         
determined by the ,speaker1 in each case
 for consideration of such provisions as
 fall within the jurisdiction of the    
committee concerned  ,a ,,bill  ,to     
amend title ,,xviii of the ,social      
,security ,act to remove from the list  
of drugs excluded from coverage under   
the ,medicare prescription drug program 
prescription oral vitamins and mineral  
products indicated for the treatment of 
iron deficiency anemia in individuals   
with chronic kidney disease4  #a4 ,short
 title ,this ,act may be cited as the   
,renal ,anemia ,innovation ,support and 
,expansion ,act or the ,,raise ,act4    

#b4 ,removing certain prescription      
vitamins and mineral products from the  
list of drugs excluded from coverage    
under the ,medicare prescription drug   
program ,section                        
#ahfj;,d-#b7;e77#b77;,a7 of the ,social 
,security ,act 7#db ,u4,s4,c4           
#aciew-#ajb7;e77#b77;,a77 is amended by 
inserting other than subparagraph 7,f7  
of such section 7relating to            
prescription vitamin and mineral        
products1 except prenatal vitamins and  
fluoride preparations7 if the           
prescription vitamin or mineral product 
is orally administered and is indicated 
for treatment of iron deficiency anemia 
in individuals with chronic kidney      
disease1 after other than subparagraph  
7,e7 of such section 7relating to       
smoking cessation agents714